Concepedia

Elizabeth Gould

EG

Statistics

Publications

14

Citations

884

H-Index

13

Active since

2011

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

PAREXEL International (United Kingdom)

GlaxoSmithKline (United Kingdom)

Janssen (Belgium)

Elizabeth Gould is an author at Research Triangle Park Foundation specializing in pharmacology, clinical pharmacology, and antiretroviral therapy.

Publications per year

2011–2018

14

Publications

14

Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial

Martin Markowitz, Ian Frank, Robert M. Grant et al. · The Lancet HIV · 2017 · 217 citations

, , +11

GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects

William Spreen, Susan L. Ford, Shuguang Chen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2014 · 150 citations

, , +13

Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults

William Spreen, Peter Williams, David M. Margolis et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2014 · 115 citations

, , +9

Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744

Susan L. Ford, Elizabeth Gould, Shuguang Chen et al. · Antimicrobial Agents and Chemotherapy · 2013 · 84 citations · Full text

, , +17

Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB‐756050, in Type 2 Diabetes

Rebecca J. Hodge, Lakshmi S. Vasist Johnson, Elizabeth Gould et al. · Clinical Pharmacology in Drug Development · 2013 · 73 citations

, , +14

1–5 of 14